Skip to content

Cognitive Behavioral Therapy Treatment of Depression With Smartphone Support

Face-to-face CBT Treatment of Depression With Smartphone Support

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01819025
Enrollment
88
Registered
2013-03-27
Start date
2013-03-31
Completion date
2014-01-31
Last updated
2014-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Depression, Behavioral activation, Smartphone application, Face-to-face, Blended therapy

Brief summary

The purpose of this study is to investigate whether face-to-face Cognitive Behavioral Therapy (CBT) with a smartphone application, focused on providing support in homework assignments and an increase in behavioral activation, is effective in treating mild to moderate depression. The study will be conducted as a randomized controlled treatment study investigating the effect of the current blended treatment compared to treatment as usual.

Detailed description

Mild to moderate depression is a major health problem, which lowers the quality of life for the individual and generates enormous costs for society. Several forms of psychotherapy have been found to be effective in the treatment of depression. Among these, behavioral activation has a strong empirical base. The efficacy of behavioral activation for treating major depressive disorders has been established in a number of studies over the last four decades. Moreover face-to-face treatments could benefit from using smartphones as an adjunct to the regular sessions, which in the case of behavioral activation treatments for depression could facilitate activity scheduling and homework, which are crucial elements of the treatment. It may also be possible to reduce the number of sessions. Since it has been shown that full behavioral activation is an effective treatment for mild to moderate depression, this study will be designed as a so-called non-inferiority study in which the treatment group, given fewer meetings face-to-face, but instead support in the form of a smartphone application. Instead of a traditional behavioral activation treatment of 10 sessions, the treatment group will be given four face-to-face CBT sessions and a smartphone app as a complement and support to the four sessions. As a control, the investigators will give full behavioral activation with 10 sessions of face-to-face therapy.

Interventions

BEHAVIORAL4 face-to-face therapy session and a smartphone-app

An 8 week blended therapy with both face-to-face therapy sessions and support through a smartphone application.

BEHAVIORALCBT, treatment as usual

10 sessions of face-to-face therapy, full behavioral activation

Sponsors

Linkoeping University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* depressive symptoms according to DSM-IV * have access to a smartphone and to the Internet * have good knowledge of the Swedish language

Exclusion criteria

* recent (during last 6 weeks) change in psychiatric medication * presently in any other psychological treatment * severe depression * suicidal ideation

Design outcomes

Primary

MeasureTime frameDescription
Patient Health Questionnaire (PHQ-9)- Change from baselineTwo weeks pre treatment, two weeks post treatment, six months and 12 months post treatmentChange from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
Beck Depression Inventory (BDI)- Change from baselineTwo weeks pre treatment, two weeks post treatment, six months and 12 months post treatmentChange from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.

Secondary

MeasureTime frameDescription
Quality of Life Inventory (QOLI)- Change from baselineTwo weeks pre treatment, two weeks post treatment, six months and 12 months post treatmentChange from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
Acceptance & Action Questionnaire (AAQ)- Change from baselineTwo weeks pre treatment, two weeks post treatment, six months and 12 months post treatmentChange from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
Beck Anxiety Inventory (BAI)- Change from baselineTwo weeks pre treatment, two weeks post treatment, six months and 12 months post treatmentChange from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
Trimbos and iMTA questionnaire on Costs associated with Psychiatric illness (TIC-P)- Change from baselineTwo weeks pre treatment and at six months post treatment.Change from baseline in health cost burden and at six months post treatment.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026